Early Recognition of Dementia:
A Phase Change in Primary Care Practice
|
Original Publish Date:
|
November 30, 2010
|
|
Review Date(s):
|
November 2011
|
|
Term of Approval End Date:
|
October 31, 2012
|
|
Estimated Time to Complete:
|
1.5 Hours
|
|
Risk Management:
|
Yes
|
|
Course Format:
|
Slide - Audio Lecture
|
|
Course Fee:
|
Mbrs-$15, Non Mbrs-$30
|
To participate in this CME activity: (1) review the information
on this page which includes the learning objectives and faculty
disclosures; (2) listen to the presentation in this session and read the
associated course pages; (3) complete the exam; (4) view/print
certificate.
Course Information
General Information
If you need to stop in the
middle of a course, you may return to the course at anytime to
finish. When you are finished viewing
the presentation slides with audio, close the window and click CME Exam
in the Course Sections box. To begin this CME activity,
read through the information on this page and then click on the Start
Course button (page bottom) or Start Course (Course Sections
box).
Course Overview
Alzheimer’s disease and other dementia represent a
looming public health crisis. An estimated 5.3 million adults in the
United States have Alzheimer’s, with approximately 5.1 million
aged 65 or older. Advancing age is clearly the greatest risk
factor for the disease.1,2 Not only are older adults
living longer lives, but baby boomers, the largest generation in
American history, are about to become older adults.1,2
In addition to the medical risk the disease poses to these older
adults, Alzheimer’s costs the country $148 billion in annual
direct and indirect costs.3 By 2050, this disease could
bankrupt Medicare.4,5 Finding a treatment that could
delay onset of Alzheimer’s disease by just five years has been
projected, over time, to cut prevalence of the disease by
half.6
Because
at least 80% of all medical care for Alzheimer’s disease and
other dementia occurs in primary care settings, including doctors'
offices, hospitals, and nursing homes (specialists initiate treatment
for dementia in only about 15% of cases)7,8 it is
crucial to assist clinicians in primary care in early symptom
recognition, accurate screening, treatment, and referral of older adults
with Alzheimer’s or other dementias or with common chronic
diseases which elevate their risk for these dementias. This CME activity
presents recommendations to encourage a shift in practice that promotes
improved levels of dementia recognition, screening, diagnosis, and
service referral.
This CME
activity is based on a live webinar held on January 26, 2010.
Hebert, LE; Scherr, PA;
Bienias, JL; Bennett, DA; and Evans, DA. “Alzheimer’s
disease in the U.S. population: Prevalence estimates using the 2000
census.” Archives of Neurology 2003: 60:1119-1122. Plassman, BL; Langa, KM;
Fisher, GG; Heeringa, SG; Weir, DR; Ofstedal, MB; et al.
“Prevalence of Dementia in the United States: The Aging,
Demographics, and Memory Study.” Neuroepidemiology 2007;
29:125-132. Alzheimer’s
Association. Alzheimer’s Disease Facts and Figures 2009;
48-59. Lewin Group. Saving
Lives, Saving Money: Dividends for Americans Investing in Alzheimer
Research (Washington, DC: Alzheimer’s Association, 2004)
accessible at http://www.alz.org, search
“Saving Lives, Saving Money.” Alzheimer’s
Association. Alzheimer’s Disease and Chronic Health Conditions:
The Real Challenge for 21st Century Medicare (Washington, DC:
Alzheimer’s Association, 2003) accessible at http://www.alz.org, search
“Alzheimer’s Disease and Chronic Health
Conditions.” Brookmeyer, et al.
1998. Borson, S. “Should
Older Adults Be Screened for Cognitive Impairment?: Underdetection of
Dementia in Primary Care Practice.” Medscape General Medicine ,
2004-03-12. Accessed October 26, 2009. Boustani M, Peterson B,
Hanson L, Harris R, Lohr KN; US Preventive Services Task Force.
Screening for dementia in primary care: a summary of the evidence for
the US Preventive Services Task Force. Ann Intern Med.
2003;138:927-937.
Back to
top
Intended Audience
This program is intended for
physicians, nurses, behavorial health specialists and other health
care professionals interested in volunteering to respond to a public
health emergency or a disaster, including current office managers,
and other staff at physician practices.
Course
Objectives
Implement a potentially
time-saving patient-centered care model designed to aid in early
recognition and treatment of dementia. Identify and cite community
resources for patients and care-partners, including the
Alzheimer’s Association Health Liaison program Integrate screening and
diagnostic tools into practice. Assist dementia patients and
their care partners in the management of major safety risks, including
noncompliance with medications.
Course Credit
Deadline for completing the course
is October 31, 2012.
The Massachusetts Medical Society
designates this enduring material for a maximum of 1.5
AMA PRA Category 1 Credits™. Physicians should
claim only credit commensurate with the extent of their participation in
the activity.
This program meets the criteria of
the Massachusetts Board of Registration in Medicine for risk management
study.
Participants will receive a
confidential report of their examination score. You must receive a score
of 70% or better to receive AMA PRA Category 1
Credit™. A confirmation of credit will be issued at the
end of the course to those who successfully complete the
examination.
This activity has been planned and
implemented in accordance with the Essential Areas and policies of the
Accreditation Council for Continuing Medical Education through the Joint
Sponsorship of the Massachusetts Medical Society and the
Massachusetts/New Hampshire Chapter of the Alzheimer's Association.
The Massachusetts Medical Society
is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
Back to
top
Course Fee
This CME activity and all
associated course materials are available free of charge. An opportunity
to complete an exam and receive AMA PRA Category 1
Credit™ for a nominal fee is available at the end of the
course. The course fees are as follows:
Massachusetts Medical Society (MMS)
Member: $15
Non-MMS member: $30
Course Materials
The presentations slides are
available for download under Tools & Resources box located
on the right of the course screen.
(Requires Adobe
Reader)
Course Faculty
Moderator: Sanford
Auerbach, MD, Associate Professor of Neurology and Psychiatry; Director,
Behavioral Neurology; Director, Sleep Disorders Center, Boston
University Medical Center; Co-chair, Medical & Scientific Advisory
Committee, Alzheimer’s Association MA/NH Chapter
Presenter: Juergen H.A. Bludau, MD, Acting Clinical Chief and Director,
Clinical Geriatric Service, Brigham and Women’s Hospital and
Faulkner Hospital; Co-chair, Medical & Scientific Advisory
Committee, Alzheimer’s Association MA/NH Chapter
Disclosure/Commercial Support
Sanford Auerbach, MD is on the
speaker’s bureau for Forest Pharmaceuticals.
Juergen H. A. Bludau, MD, CMD is co-founder of the Galaxy Institute.
The MMS has determined that any potential relevant conflicts of interest
have been resolved.
Back to
top
Off-Label Disclosure
This course does not include any
discussion of an off-label use of a commercial product or an
investigational use not yet approved for any purpose by the FDA.
Commercial Support
No commercial support was received
for this online program.
Content Disclaimer
The views expressed are not
necessarily those of the Massachusetts Medical Society.
Back to
top
Course
Developers
Online Course
Developers
Kathleen Bellisle, Manager of Distance Learning, MMS
Thelma Tatten, Distance Learning Project Coordinator, MMS
Bibliography
Alzheimer’s
Association www.alz.org
(nationwide) www.alz.org/MANH
(MA/NH Chapter) Alzheimer’s
Association. Alzheimer’s Disease Study: Communication Gaps between
Primary Care Physicians and Caregivers. (New York, NY: Roper Starch
Worldwide, 2001). Phone survey conducted on behalf of the
Alzheimer’s Association by Roper Starch Worldwide, Inc. Accessible
at http://greenfield.alz.org. 10 Signs of Alzheimer's (from the Alzheimer's
Association, Massachusetts and New Hampshire Chapter) Hebert, LE; Scherr, PA;
Bienias, JL; Bennett, DA; and Evans, DA. “Alzheimer’s disease in the U.S. population:
Prevalence estimates using the 2000 census.” Archives of
Neurology 2003: 60:1119-1122. Plassman, BL; Langa, KM;
Fisher, GG; Heeringa, SG; Weir, DR; Ofstedal, MB; et al.
“Prevalence of Dementia in the United States: The Aging,
Demographics, and Memory Study.” Neuroepidemiology 2007;
29:125-132.
Lewin Group. Saving Lives, Saving Money: Dividends for
Americans Investing in Alzheimer Research (Washington, DC:
Alzheimer’s Association, 2004) accessible at http://www.alz.org, search “Saving
Lives, Saving Money.”
Alzheimer’s Association. Alzheimer’s Disease
and Chronic Health Conditions: The Real Challenge for 21st Century
Medicare (Washington, DC: Alzheimer’s Association, 2003)
accessible at http://www.alz.org,
search “Alzheimer’s Disease and Chronic Health
Conditions.”
For a complete bibliography, please refer to the last three slides of
the presentation slides
Back to
top
Hardware & Software Requirements
Supported
Browsers
Internet Explorer v.7 or greater (for Windows)
Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)
Minimum System
Requirements
Windows Systems Requirements
A Pentium-based PC or compatible
computer.
At least 64MB of RAM.
Windows 95/98/NT/ME/2000/XP/Vista system software.
A Sound Blaster or compatible sound card and speakers.
DirectX version 3.0 or later recommended.
Screen resolution of 1024 x 786 or larger recommended.
Browser Plug-in: Adobe Flash
Player version 9 or higher.
PDF Reader: Adobe
Reader 5.0 or higher, Foxit
Reader 2.0 or likewise.
Mac OS System
Requirements
A PowerPC processor-based Macintosh
computer.
At least 64MB of RAM.
Mac OS 7.5 or later.
Screen resolution of 1024 x 786 or larger recommended.
Browser Plug-in: Adobe Flash
Player version 9 or higher.
PDF Reader: Adobe
Reader 5.0 or higher, Foxit
Reader 2.0 or likewise.
Back to
top
Policies
Copyright
Policy
Privacy
Policy
Contact Us
Contact us at continuingeducation@mms.org
or (800) 322-2303, ext. 7306. Massachusetts Medical Society, 860 Winter
Street, Waltham, MA 02451.
Back to top
|
